000 01459 a2200445 4500
005 20250517215711.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1477-0962
024 7 _a10.1177/0961203318776085
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMahmoud, G A
245 0 0 _aClinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.
_h[electronic resource]
260 _bLupus
_cAug 2018
300 _a1562-1569 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntimalarials
_xtherapeutic use
650 0 4 _aAzathioprine
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aEgypt
_xepidemiology
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLupus Erythematosus, Systemic
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aRetrospective Studies
650 0 4 _aYoung Adult
700 1 _aShahin, A A
700 1 _aZayed, H S
700 1 _aMoghazy, A
700 1 _aEissa, B M
773 0 _tLupus
_gvol. 27
_gno. 9
_gp. 1562-1569
856 4 0 _uhttps://doi.org/10.1177/0961203318776085
_zAvailable from publisher's website
999 _c28418114
_d28418114